Histopathological spectrum of ovarian tumours
DOI:
https://doi.org/10.18203/2349-3259.ijct20242673Keywords:
Ovarian, Neoplasms, HistopathologyAbstract
Background: Ovarian neoplasms include wide spectrum of various tumors, which differ in their histo-morphological features, also in their biological behaviour, tumorigenesis, clinical course, and prognosis. Aim of the study was to study the histopathological features of various ovarian tumors and correlate preoperative serum CA125 tumor marker level with histopathological types. Also to study fallopian tubes for fallopian tube precursor lesions such as serous tubal intraepithelial carcinoma (STIC) in serous carcinoma ovary.
Methods: This cross-sectional observational study of the 80 specimens of ovarian tumors was conducted in department of pathology, Netaji Subhash Chandra Bose medical college Jabalpur (M.P.). The relevant data of the patients was collected and analysed as per designed proforma.
Results: Out of 80 cases; majority cases 22 (27.5%) were seen in a 31-40 years age group, followed by 41-50 years age group 18 cases (22.5%). Youngest patient was 7 years old and oldest patient was 88 years old, forming the range of 7 years to 88 years. Epithelial tumors were the most common category, followed by germ cell tumors, sex cord stromal tumors and metastatic tumors. Benign tumors were much higher than borderline and malignant tumors mature cystic teratoma was the most common tumor encountered, followed by mucinous cystadenoma. The commonest malignant tumor was serous carcinoma followed by mucinous carcinoma.
Conclusions: Ovarian neoplasms constitute a wide spectrum of tumors therefore exact categorization is important to adopt appropriate treatment protocols for the proper management of the patient. Histopathological examination is the gold standard for diagnosis and categorization of ovarian neoplasm.
Metrics
References
Torre LA, Trabert B, DeSantis CE, Miller KKD, Samimi G, Runowicz CD, et al. Ovarian Cancer Statistics 2018. CA cancer J clin. 2018;68(4):284-96.
Kumar V, Abbas AK, Aster JC, Sign M. Robbins and Cotran pathologic basis of disease, vol. II. The Female Genital Tract, Ovaries. Tenth edition. 2020;1016-9.
Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, et al. Global Cancer Observatory: Cancer Today. Lyon, France. Int Agency Res Cancer. 2024. Available at: https://gco.iarc.who.int/today. Accessed on 15 June 2024.
Takiar R. Status of Ovarian Cancer in India (2012-14). EC Gynaecol; 2019;8.5:358-64.
Karst AM, Drapkin R. Ovarian Cancer Pathogenesis: A Model in Evolution. J Oncol. 2010;932371:13.
Gupta D, Lis CG. Role of CA125 in predicting ovarian cancer survival-a review of the epidemiological literature. J Ovarian Res. 2009;2:13.
College of American Pathologists (CAP). Protocol for examination of specimens from patients with primary tumors of ovary, fallopian tube, or peritonium. 2018.
WHO Classification of female reproductive organs. International Agency for research on cancer, 4th Edition. 2014. Available at: https://publications. iarc.fr/Book-And-Report-Series/Who-Classification-Of-Tumours/WHO-Classification-Of-Tumours-Of-Female-Reproductive-Organs-2014. Accessed on 3 June 2024.
Garg N, Anand AS, Annigeri C. Study of histopathological spectrum of ovarian tumors, Raichur, Karnataka. Int J Med Heal Res. 2017;3(10):12-20.
Patel AS, Patel JM, Kamlesh SJ. Ovarian tumors-Incidence and histopathological spectrum in tertiary care center, Valsad. IAIM. 2018;5(2):84-93.
Chandanwale SS, Jadhav R, Rao R, Naragude P, Bhamnikar S, Ansari JN. Clinicopathologic study of malignant ovarian tumors: A study of fifty cases. Med J DY Patil Univ. 2017;10:430-7.
Sarabjeet K, Jassal V, Bodal VK. A study of histological pattern of ovarian carcinoma in tertiary care Hospital Punjab. Int J Curr Res Biol. 2018;3(3):63-70.
Sudha V, Harikrishan V, Sridevi M, Priya P. Clinicopathological correlation of ovarian tumors in a tertiary care hospital. Indian J Pathol Oncol. 2018;5(2):332-3.
Sofi MA, Bashir N, Afshan KA, Ali K. Histopathological Pattern of Ovarian tumors-An Experience. Int J Clin Diagnost Pathol. 2019;2(2):15-21.
Dutta A, Reshma I, Saikia P, Borgohain4 M. Histopathological spectrum of ovarian neoplasms in a tertiary care hospital. Int J Contemporary Med Res. 2018;5(8):H1-4.
Mankar DV, Jain GK. Histopathological profile of ovarian tumours: A twelve year institutional experience. Muller J Med Sci Res. 2015;6:107-11.
Gupta N, Yadav M, Gupta V, Chaudhary D, Patne SCU. Distribution of various histopathological types of ovarian tumors: A study of 212 cases from a tertiary care center of Eastern Uttar Pradesh. J Lab Physicians. 2019;11(1):75-81.
Ashwani N, Chaitra S, Padma K, Swarup A, Cherukumudi A, Chandran PR. Correlation between CA 125 and Staging and Histopathological Type of Ovarian Cancer. J Med Sci Clin Res. 2015;3(11):NA.
Kurman RJ, Ellenson LH, Ronnett BM. Blaustein's pathology of the female genital tract Disease of fallopian tube and paratubal region, (sixth ed.); New York: Springer. 2011;560.
Chaudhary VK, Solanki R. Association of high-grade serous ovarian carcinoma with intraepithelial carcinoma of fallopian tube. Int J Med Sci Public Health. 2016;5:1956-9.
Morrison JC, Blanco LZ Jr, Vang R, Ronnett BM. Incidental serous tubal intraepithelial carcinoma and early invasive serous carcinoma in nonprophylactic setting: analysis of a case series. Am J Surg Pathol. 2015;39(4):442-53.
Kindleberger DW, Lee Y, Miron A, Hirsch MS, Feltmate C, Medeiros F, et al. Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship. Am J Surg Pathol. 2007;31(2):161-9.
Downloads
Published
How to Cite
Issue
Section
